Radiation Therapy For The Whole Breast

Publication Date: March 1, 2018
Last Updated: March 14, 2022

Recommendations for patients receiving WBI without additional fields to cover the regional lymph nodes

Overall Statement

For women with invasive breast cancer receiving WBI with or without inclusion of the low axilla, the preferred dose-fractionation scheme is HF-WBI to a dose of 4000 cGy in 15 fractions or 4250 cGy in 16 fractions. (Strong, High)

When should patients receive a tumor bed boost in conjunction with WBI?

Age, grade, margins, and biology for invasive disease

A tumor bed boost is recommended for patients with invasive breast cancer who meet any of the following criteria: age ≤50 years with any grade, age 51 to 70 years with high grade, or a positive margin. (Strong, Moderate)



Radiation Therapy For The Whole Breast

Authoring Organization